- Home
- UOKA vs PTIX Comparison
UOKA vs PTIX Comparison
Compare UOKA & PTIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- UOKA
- PTIX
- Stock Information
- Founded
- UOKA 2002
- PTIX 1994
- Country
- UOKA United Kingdom
- PTIX United States
- Employees
- UOKA N/A
- PTIX N/A
- Industry
- UOKA
- PTIX Biotechnology: Pharmaceutical Preparations
- Sector
- UOKA
- PTIX Health Care
- Exchange
- UOKA NYSE
- PTIX Nasdaq
- Market Cap
- UOKA 3.7M
- PTIX 3.7M
- IPO Year
- UOKA N/A
- PTIX 2016
- Fundamental
- Price
- UOKA $0.27
- PTIX $0.70
- Analyst Decision
- UOKA
- PTIX
- Analyst Count
- UOKA 0
- PTIX 0
- Target Price
- UOKA N/A
- PTIX N/A
- AVG Volume (30 Days)
- UOKA 15.4M
- PTIX 258.9K
- Earning Date
- UOKA 02-16-2025
- PTIX 11-14-2024
- Dividend Yield
- UOKA N/A
- PTIX N/A
- EPS Growth
- UOKA N/A
- PTIX N/A
- EPS
- UOKA N/A
- PTIX N/A
- Revenue
- UOKA $114,849.00
- PTIX N/A
- Revenue This Year
- UOKA N/A
- PTIX N/A
- Revenue Next Year
- UOKA N/A
- PTIX N/A
- P/E Ratio
- UOKA N/A
- PTIX N/A
- Revenue Growth
- UOKA 289.97
- PTIX N/A
- 52 Week Low
- UOKA $0.14
- PTIX $0.45
- 52 Week High
- UOKA $1.90
- PTIX $1.87
- Technical
- Relative Strength Index (RSI)
- UOKA N/A
- PTIX 55.96
- Support Level
- UOKA N/A
- PTIX $0.50
- Resistance Level
- UOKA N/A
- PTIX $0.56
- Average True Range (ATR)
- UOKA 0.00
- PTIX 0.06
- MACD
- UOKA 0.00
- PTIX 0.01
- Stochastic Oscillator
- UOKA 0.00
- PTIX 84.31
About UOKA MDJM LTD
MDJM Ltd is a real estate service company. The company provides real estate agency services to real estate developer clients, as well as real estate consulting services and independent training services on an as-needed basis. It offers consulting, marketing planning, advertising services, and sales strategies to real estate clients. The company income is derived from commission-based services and minimal consulting and other services. The company has two operating segments; the real estate agent services segment and the hospitality business segment. It derives a majority of its revenue from the People's Republic of China.
About PTIX Protagenic Therapeutics Inc.
Protagenic Therapeutics Inc is a biopharmaceutical company focused on the discovery and development of therapeutics to treat stress-related neuropsychiatric and mood disorders. It provides treatments for mood, anxiety, depression, and neurodegenerative disorders by using peptide-based and brain-active therapeutics. The company's lead compound, PT00114, is a synthetic form of Teneurin Carboxy-terminal Associated Peptide, an endogenous brain signaling peptide that can dampen overactive stress responses. It has also created a portfolio of novel neuropeptides that are in various stages of development and preclinical evaluation for the treatment of mood disorders.